DIAGNOS (CVE:ADK) Sets New 12-Month High – Still a Buy?

DIAGNOS Inc. (CVE:ADK) shares hit a new 52-week high on Thursday . The company traded as high as C$0.41 and last traded at C$0.40, with a volume of 1041344 shares trading hands. The stock had previously closed at C$0.39.

DIAGNOS Trading Up 2.6%

The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The stock’s fifty day simple moving average is C$0.25 and its 200 day simple moving average is C$0.26. The firm has a market capitalization of C$47.56 million, a PE ratio of -9.88 and a beta of -0.14.

Insider Activity at DIAGNOS

In other news, Director Robert Dunn bought 200,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The shares were bought at an average price of C$0.30 per share, for a total transaction of C$60,000.00. Following the purchase, the director owned 2,117,778 shares in the company, valued at C$635,333.40. This represents a 10.43% increase in their ownership of the stock. In the last 90 days, insiders have acquired 328,571 shares of company stock worth $96,000. 16.81% of the stock is owned by company insiders.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.